186 related articles for article (PubMed ID: 33923428)
1. Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials.
Leelapatana P; Thongprayoon C; Prasitlumkum N; Vallabhajosyula S; Cheungpasitporn W; Chokesuwattanaskul R
Diseases; 2021 Apr; 9(2):. PubMed ID: 33923428
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
De Vecchis R; Ariano C; Giasi A; Cioppa C
Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
[TBL] [Abstract][Full Text] [Related]
3. Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials.
Gong M; Zhang Z; Fragakis N; Korantzopoulos P; Letsas KP; Li G; Yan GX; Liu T
Heart Rhythm; 2017 Jan; 14(1):3-11. PubMed ID: 27746384
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis.
Guerra F; Romandini A; Barbarossa A; Belardinelli L; Capucci A
Int J Cardiol; 2017 Jan; 227():284-291. PubMed ID: 27839812
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy.
Tsanaxidis N; Aidonidis I; Hatziefthimiou A; Daskalopoulou SS; Giamouzis G; Triposkiadis F; Skoularigis I
Pacing Clin Electrophysiol; 2017 Apr; 40(4):372-378. PubMed ID: 28182279
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients.
Simopoulos V; Hevas A; Hatziefthimiou A; Dipla K; Skoularigis I; Tsilimingas N; Aidonidis I
Cardiovasc Drugs Ther; 2018 Dec; 32(6):559-565. PubMed ID: 30255400
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.
Fragakis N; Koskinas KC; Katritsis DG; Pagourelias ED; Zografos T; Geleris P
Am J Cardiol; 2012 Sep; 110(5):673-7. PubMed ID: 22621799
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
Miles RH; Passman R; Murdock DK
Am J Cardiol; 2011 Sep; 108(5):673-6. PubMed ID: 21726841
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis.
Letelier LM; Udol K; Ena J; Weaver B; Guyatt GH
Arch Intern Med; 2003 Apr; 163(7):777-85. PubMed ID: 12695268
[TBL] [Abstract][Full Text] [Related]
11. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
[TBL] [Abstract][Full Text] [Related]
12. The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.
Hartmann N; Mason FE; Braun I; Pabel S; Voigt N; Schotola H; Fischer TH; Dobrev D; Danner BC; Renner A; Gummert J; Belardinelli L; Frey N; Maier LS; Hasenfuss G; Sossalla S
J Mol Cell Cardiol; 2016 May; 94():95-106. PubMed ID: 27056421
[TBL] [Abstract][Full Text] [Related]
13. An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis.
Zaki HA; Bashir K; Iftikhar H; Salem W; Mohamed EH; Elhag HM; Hendy M; Kassem AAO; Salem EE; Elmoheen A
Cureus; 2022 Jul; 14(7):e26800. PubMed ID: 35971374
[TBL] [Abstract][Full Text] [Related]
14. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
Dagres N; Iliodromitis EK; Lekakis JP; Simitsis P; Karatzas D; Rallidis LS; Simeonidou E; Anastasiou-Nana M
J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):254-9. PubMed ID: 24662415
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.
Cadrin-Tourigny J; Wyse DG; Roy D; Blondeau L; Levesque S; Talajic M; Andrade JG; Dubuc M; Thibault B; Guerra PG; Macle L; Rivard L; Khairy P
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1306-13. PubMed ID: 25181386
[TBL] [Abstract][Full Text] [Related]
19. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Longas-Tejero MA; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2012 May; (5):CD005049. PubMed ID: 22592700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
